“The FDA has offered little evidence of systemic test failure that would justify these sweeping regulatory changes and it does not have the statutory authority to regulate physicians engaged in the practice of medicine as it is proposing,” said CEO and Executive Vice President of the American Medical Association, James L. Madara, MD. “The agency also does not have the resources to successfully implement its proposal without impeding on the current standard of care and creating marked delays in medical advancement.”
Click here to read the AMA’s submitted comments in full.
More articles on ASC issues:
Getting the most out of Facebook for your business: 5 tips
155 ASC industry physician leaders to know
Robinwood Surgery Center to close Feb. 20
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
